Insider · CIK 0001496194

Naftzger J. Christopher

Reports to the SEC for 3 companies · LEWISBERRY, PA

sec.gov

Transactions

Companies

Filings

CIK

0001496194

Forms 4 and 5

Insider transactions

22 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-02-14	ABUSArbutus Biopharma CorpA Award	General Counsel and CCO	AAward	+54.3K sh	—	—	140,544
2025-02-14	ABUSArbutus Biopharma Corp · Stock Option (Right to Buy)A Award	General Counsel and CCO	AAward	+220K sh	—	—	220,300
2025-02-04	ABUSArbutus Biopharma CorpS Sale	General Counsel and CCO	SSale	−11.3K sh	$3.28	−$37.2K	86,244
2024-02-01	ABUSArbutus Biopharma CorpA Award	General Counsel and CCO	AAward	+95.1K sh	—	—	95,100
2024-02-01	ABUSArbutus Biopharma Corp · Stock Option (Right to Buy)A Award	General Counsel and CCO	AAward	+381K sh	—	—	380,500
2023-07-10	ABUSArbutus Biopharma Corp · Stock Option (Right to Buy)A Award	General Counsel and CCO	AAward	+500K sh	—	—	500,000
2022-08-11	Nabriva Therapeutics plcShare OptionsM Exercise/Conversion	General Counsel and Corp Sec	MExercise/Conversion	−63.2K sh	—	—	0
2022-08-11	Nabriva Therapeutics plcRestricted Stock UnitsM Exercise/Conversion	General Counsel and Corp Sec	MExercise/Conversion	−31.6K sh	—	—	0
2022-08-11	Nabriva Therapeutics plcStock Appreciation RightM Exercise/Conversion	General Counsel and Corp Sec	MExercise/Conversion	+63.2K sh	—	—	63,200
2022-08-11	Nabriva Therapeutics plcPhantom SharesM Exercise/Conversion	General Counsel and Corp Sec	MExercise/Conversion	+31.6K sh	—	—	31,600
2022-01-28	Nabriva Therapeutics plcShare OptionsA Award	General Counsel and Corp Sec	AAward	+63.2K sh	—	—	63,200
2022-01-28	Nabriva Therapeutics plcRestricted Stock UnitsA Award	General Counsel and Corp Sec	AAward	+31.6K sh	—	—	31,600
2021-12-27	Nabriva Therapeutics plcP Purchase	General Counsel and Corp Sec	PPurchase	+7,000 sh	$0.59	+$4,130	7,000
2021-09-30	Nabriva Therapeutics plcShare OptionA Award	General Counsel and Corp Sec	AAward	+100K sh	—	—	100,000
2013-05-28	Unilife CorpA Award	See Remarks	AAward	+165K sh	—	—	224,440
2012-03-20	Unilife CorpA Award	See Remarks	AAward	+17.5K sh	—	—	59,440
2011-11-22	Unilife CorpP Purchase	See Remarks	PPurchase	+2,000 sh	$3.96	+$7,910.4	41,940
2011-11-14	Unilife CorpF Tax Payment	See Remarks	FTax Payment	−3,060 sh	$4.62	−$14.1K	39,940
2011-03-01	Unilife CorpP Purchase	See Remarks	PPurchase	+3,000 sh	$4.70	+$14.1K	43,000
2011-01-03	Unilife CorpStock Option (Right to Buy)A Award	See Remarks	AAward	+12.8K sh	—	—	12,821
2010-07-06	Unilife CorpA Award	See Remarks	AAward	+40K sh	—	—	40,000
2010-07-06	Unilife CorpStock Option (Right to Buy)A Award	See Remarks	AAward	+60K sh	—	—	60,000

Recent filings

Accepted (ET)
Feb 194
Naftzger J. Christopher0001447028-25-000052
SEC(opens sec.gov)
Feb 54
Naftzger J. Christopher0001447028-25-000037
SEC(opens sec.gov)
Feb 54
Naftzger J. Christopher0001447028-24-000029
SEC(opens sec.gov)
Jul 124
Naftzger J. Christopher0001447028-23-000066
SEC(opens sec.gov)
Aug 154
Naftzger J. Christopher0001104659-22-091488
SEC(opens sec.gov)
Feb 14
Naftzger J. Christopher0001104659-22-010484
SEC(opens sec.gov)
Dec 284
Naftzger J. Christopher0001104659-21-154012
SEC(opens sec.gov)
Oct 14
Naftzger J. Christopher0001104659-21-121964
SEC(opens sec.gov)
May 304
Naftzger J. Christopher0001209191-13-029693
SEC(opens sec.gov)
Mar 224
Naftzger J. Christopher0001209191-12-019491
SEC(opens sec.gov)
Nov 224
Naftzger J. Christopher0001209191-11-057710
SEC(opens sec.gov)
Nov 144
Naftzger J. Christopher0001209191-11-055942
SEC(opens sec.gov)
Mar 24
Naftzger J. Christopher0001209191-11-014476
SEC(opens sec.gov)
Jan 54
Naftzger J. Christopher0001209191-11-001997
SEC(opens sec.gov)

Companies

Address

C/O 633 LOWTHER ROAD

LEWISBERRY, PA, 17339